Skip to main content
SpringerLink
Log in

The Cognitive Cytokine Effect of Nonsteroidal Antiinflammatory Drugs in the Treatment of Elderly Patients with Osteoarthritis

  • Published:
Advances in Gerontology Aims and scope Submit manuscript

Abstract

The goal of this study was to evaluate the effect of long-term nonsteroidal antiinflammatory drug (NSAID) therapy on the severity of cognitive deficiency in elderly patients with osteoarthritis (OA) and the relationship between this effect and cytokine fluctuations in the blood serum of the patients. This prospective observational study took 540 ± 5.5 days and was conducted in two stages: phase I consisted of active medication therapy based on NSAIDs, and phase II was connected with nonpharmacological OA management. A cohort of 128 OA patients aged 65–75 years (the mean age was 70 ± 4.6 years, 10.2% men and 89.8% women) participated in the study. Patients from the main group were divided into four subgroups: the first group (n = 30) received etoricoxib at a daily dose of 60 mg, the second group (n = 32) took celecoxib at a daily dose of 200 mg, the third group (n = 32) was given a daily 100-mg dose of nimesulid, and the patients of the fourth group (n = 34) took meloxicam at a daily dose of 7.5 mg. The control group was formed of 40 patients with OA having analogous clinical and demographic characteristics and not taking NSAIDs in the previous six months and in the course of the study. The initial stiffness and pain indices were measured in all patients by the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) subscales, while their condition was evaluated during all visits to the clinic by the Montreal Cognitive Assessment (MoCA) Scale along with laboratory investigations for the blood serum contents of Transforming Growth Factor (TGF)-β1, Interleukin (IL)-1β, and IL-6. Statistically significant decreases in the levels of cytokines were recorded in the period from the first to the third visits in all patients of the main group, as were increases in the indices of cognitive functions by the MoCA scale with a high degree of correlation relative to the cytokine indicators were observed by the end of the study. The results of the study have allowed us to suggest that the NSAID therapy may have an effect on the cognitive functions of elderly patients with OA in real clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Karataev, A.E., Nasonov, E.L., Yakhno, N.N., et al., Clinical recommendations “Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice,” Sovrem. Revmatol., 2015, vol. 9, no. 1, pp. 4–23.

    Google Scholar 

  2. Seminskii, I.Zh., Serebrennikova, S.N., Guzovskaya, E.V., et al., The role of cytokines in the pathogenesis. Part 2, Sib. Med. Zh. (Irkutsk), 2015, vol. 1, pp. 14–17.

    Google Scholar 

  3. Freidlin, I.S., Paracrine and autocrine mechanisms of cytokine immunoregulation, Immunologiya, 2001, vol. 5, pp. 4–7.

    Google Scholar 

  4. Altman, R., Asch, E., Bloch, D., et al., Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association, Arthritis Rheum., 1986, vol. 29, no. 8, pp. 1039–1049.

    Article  CAS  PubMed  Google Scholar 

  5. Bellamy, N., Buchanan, W.W., Goldsmith, C.H., et al., Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J. Rheumatol., 1988, vol. 15, no. 12, pp. 1833–1840.

    CAS  PubMed  Google Scholar 

  6. Blaney Davidson, E.N., van der Kraan, P.M., and van den Berg, W.B., TGF-β and osteoarthritis, Osteoarthritis Cartilage, 2007, vol. 15, no. 6, pp. 597–604.

    Article  CAS  PubMed  Google Scholar 

  7. Breitner, J.C., Baker, L.D., Montine, T.J., et al., Extended results of the Alzheimer’s disease antiinflammatory prevention trial, Alzheimer’s Dementia, 2011, vol. 7, pp. 402–411.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bruyère, O., Cooper, C., Pelletier, J.P., et al., A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—from evidence-based medicine to the real-life setting, Semin. Arthritis Rheum., 2016, vol. 45, pp. 3–11.

    Article  Google Scholar 

  9. De Lange-Brokaar, B.J., Ioan-Facsinay, A., van Osch, G.J., et al., Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review, Osteoarthritis Cartilage, 2012, vol. 20, no. 12, pp. 1484–1499.

    Article  PubMed  Google Scholar 

  10. Goldring, S.R. and Goldring, M.B., The role of cytokines in cartilage matrix degeneration in osteoarthritis, Clin. Orthopaed. Relat. Res., 2004, vol. 427, pp. 27–36.

    Article  Google Scholar 

  11. Huang, S.W., Wang, W.T., Chou, L.C., et al., Osteoarthritis increases the risk of dementia: A nationwide cohort study in Taiwan, Sci. Rep., 2015, vol. 5, p. 10145.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hebert, L.E., Scherr, P.A., Bienias, J.L., et al., Alzheimer disease in the US population: prevalence estimates using the 2000 census, Arch. Neurol., 2003, vol. 60, pp. 1119–1122.

    Article  PubMed  Google Scholar 

  13. Hoozemans, J.J., Bruckner, M.K., Rozemuller, A.J., et al., Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex, J. Neuropathol. Exp. Neurol., 2002, vol. 61, pp. 678–688.

    Article  CAS  PubMed  Google Scholar 

  14. Kyrkanides, S., Tallents, R.H., Miller, J.H., et al., Osteoarthritis accelerates and exacerbates Alzheimer’s disease pathology in mice, J. Neuroinflammation, 2011, vol. 8, p. 12.

    Article  Google Scholar 

  15. Marcu, K.B., Otero, M., Olivotto, E., et al., NF-κB signaling: multiple angles to target OA, Curr. Drug Targets, 2010, vol. 11, no. 5, pp. 599–613.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Melnikova, T., Savonenko, A., Wang, Q., et al., Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern, Neuroscience, 2006, vol. 141, pp. 1149–1162.

    Article  CAS  PubMed  Google Scholar 

  17. Mueller, M.B. and Tuan, R.S., Anabolic/catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets, PM&R, 2011, vol. 3, no. 6, pp. 3–11.

    Article  Google Scholar 

  18. Nasreddine, Z.S., Phillips, N.A., Bedirian, V., et al., The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment, J. Am. Geriatr. Soc., 2005, vol. 53, pp. 695–699.

    PubMed  Google Scholar 

  19. Sil, S. and Ghosh, T., Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicines induced rat model of Alzheimer’s disease, J. Neuroimmunol., 2016, vol. 291, pp. 115–124.

    Article  CAS  PubMed  Google Scholar 

  20. Sohn, D.H., Sokolove, J., Sharpe, O., et al., Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4, Arthritis Res. Ther., 2012, vol. 14, no. 1, p. 7.

    Article  Google Scholar 

  21. Yang, H., Zhang, J., Andreasson, K., and Chen, C., COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity, Mol. Cell Neurosci., 2008, vol. 37, pp. 682–695.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yermakova, A.V. and O’Banion, M.K., Down regulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer’s disease, Neurobiol. Aging, 2001, vol. 22, pp. 823–836.

    Article  CAS  PubMed  Google Scholar 

  23. Vangsness, C.T., Jr., Burke, W.S., Narvy, S.J., et al., Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis—a pilot study, Bull. Hosp. Jt. Dis., 2011, vol. 69, no. 2, pp. 122–127.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Samara State Medical University, Samara, 443099, Russia

    I. A. Zolotovskaya & I. L. Davydkin

Authors
  1. I. A. Zolotovskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. L. Davydkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. A. Zolotovskaya.

Additional information

Original Russian Text © I.A. Zolotovskaya, I.L. Davydkin, 2017, published in Uspekhi Gerontologii, 2017, Vol. 30, No. 3, pp. 381–389.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zolotovskaya, I.A., Davydkin, I.L. The Cognitive Cytokine Effect of Nonsteroidal Antiinflammatory Drugs in the Treatment of Elderly Patients with Osteoarthritis. Adv Gerontol 8, 26–32 (2018). https://doi.org/10.1134/S2079057018010149

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079057018010149

Keywords

Search

Navigation